Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine.
about
Olesoxime (cholest-4-en-3-one, oxime): analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxelChemotherapy-induced peripheral neuropathy: an update on the current understandingPaclitaxel-induced epithelial damage and ectopic MMP-13 expression promotes neurotoxicity in zebrafishTargeting neuroprotection as an alternative approach to preventing and treating neuropathic painMitotoxicity in distal symmetrical sensory peripheral neuropathiesAn integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US.Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound.Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain.Pain in cancer survivorsEnhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathyCombining ketamine with astrocytic inhibitor as a potential analgesic strategy for neuropathic pain ketamine, astrocytic inhibitor and pain.Sensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons.Increased spinal cord Na⁺-K⁺-2Cl⁻ cotransporter-1 (NKCC1) activity contributes to impairment of synaptic inhibition in paclitaxel-induced neuropathic painThe response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries.Pain, neuropathic symptoms, and physical and mental well-being in persons with cancer.Genesis of anxiety, depression, and ongoing abdominal discomfort in ulcerative colitis-like colon inflammation.Terminal arbor degeneration--a novel lesion produced by the antineoplastic agent paclitaxel.Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy.Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy.Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat.Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin.Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In VivoDiscovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells.NON-INVASIVE EVALUATION OF NERVE CONDUCTION IN SMALL DIAMETER FIBERS IN THE RAT.Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μ.EXPRESS: Methylcobalamin ameliorates neuropathic pain induced by vincristine in rats: Effect on loss of peripheral nerve fibers and imbalance of cytokines in the spinal dorsal horn.Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathyMechanical sensitization of cutaneous sensory fibers in the spared nerve injury mouse model.A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.Altered rate-dependent depression of the spinal H-reflex as an indicator of spinal disinhibition in models of neuropathic painStrength and balance training for adults with peripheral neuropathy and high risk of fall: current evidence and implications for future research.Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence.Pain and death: neurodegenerative disease mechanisms in the nociceptor.Acetyl-L-carnitine: from a biological curiosity to a drug for the peripheral nervous system and beyond.Brief review: chemotherapy-induced painful peripheral neuropathy (CIPPN): current status and future directions.Chemotherapy induced peripheral neuropathic painSkin Matters: A Review of Topical Treatments for Chronic Pain. Part One: Skin Physiology and Delivery Systems.Melatonin limits paclitaxel-induced mitochondrial dysfunction in vitro and protects against paclitaxel-induced neuropathic pain in the rat.
P2860
Q24646451-2C0E5426-3E84-48D3-A37E-BEAA238B4A54Q26740689-228B5806-361E-46E1-833A-00EB57F07B8BQ27316580-DC751A36-52A2-4D72-8184-78A27EF78FC1Q28820780-E9918ACD-0211-40F4-B377-C74B7B5590D9Q28834071-1CDF5F39-DFC9-4FEB-AB26-F4D6DF59B5AAQ30236003-53B31E1F-AD56-46C6-83F5-0E5798F57FACQ31135310-993D6200-7481-4C8E-A8FB-F9CD750FC3A7Q33610537-939711A5-C3ED-4594-9448-362AD7BB13D3Q33650576-C1821C2A-5128-49FF-834C-2B796644A7BFQ33650951-903CD279-845A-45DE-9E02-FC05034487EBQ34142195-8533002D-C845-4707-9EBF-F10341D08D44Q34412078-682DDB5E-A69E-4BB0-81C2-8B46F6733BD5Q34467512-08833D6C-F98C-48F3-B210-570704770DECQ34579481-7B813DE3-7F44-4201-A36B-855CFCF8497EQ34762806-E34A64ED-4AB3-4A0C-AEE0-59023DF426A9Q34800903-60B10D39-A75D-4743-864D-39072D3B9856Q34917256-25E83740-8B03-47B5-A439-31BDD0DB4ED9Q35138445-1680B2C0-6AD6-44C0-AD15-44C24DB050B1Q35449249-26A2A12A-66D4-48D1-82C0-F7AAD946F6F2Q35613627-1B2984E8-CB82-47B6-B49A-87CE6E5D4E51Q35740234-0AF25D2E-9336-43DB-AF62-841322F4975BQ35784775-554E8370-08F8-426B-966A-F148D5D08C3EQ35903899-6EC35A6A-3CEA-4131-8E53-DE06163AD406Q36439933-E86FB685-7060-4C46-B3A9-3154D7E22D0AQ36571464-E010628B-4D40-4EE3-8C51-CF2DDE7A3F06Q36750823-822A8D1E-4259-4D99-9D3C-B1134E360155Q36988206-0C45726D-CCF7-42CF-87A0-9C97017B4986Q37114802-BC5F114C-4E76-4B0D-BEF4-C4C40EBCF6CBQ37216797-7DD97AF7-BABE-4A8C-B359-ED1B15AC751DQ37532665-88ACC248-2E83-4653-8919-4E647373FD2AQ37582203-33282146-4EA6-476D-90CA-4D4B09E26B16Q37625422-31E6FAC8-0F96-4C3F-B2EF-E76C0AA34CAAQ37744253-77D02EF1-4244-4D45-9D5F-30EA1216F9D2Q37826427-4B8D5F42-879D-46F6-BF9E-BACD247BCDCEQ37833572-45246F67-15C3-4EE9-8005-7003EC624CF1Q38130554-E130538C-E706-4B2F-AF49-55104F5773EBQ38209959-7FAD11E4-B3E4-4339-92EC-082CF780080DQ38237393-52EF07E2-51C3-4432-84A9-3C65D6FF7183Q38334849-466975BE-B2A6-4B01-BB13-B2C09EC9526CQ38694326-C7BF14AC-7C80-4538-84D9-E1A4A734F55E
P2860
Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 July 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemotherapy-evoked neuropathi ...... ression by acetyl-L-carnitine.
@en
Chemotherapy-evoked neuropathi ...... ression by acetyl-L-carnitine.
@nl
type
label
Chemotherapy-evoked neuropathi ...... ression by acetyl-L-carnitine.
@en
Chemotherapy-evoked neuropathi ...... ression by acetyl-L-carnitine.
@nl
prefLabel
Chemotherapy-evoked neuropathi ...... ression by acetyl-L-carnitine.
@en
Chemotherapy-evoked neuropathi ...... ression by acetyl-L-carnitine.
@nl
P2860
P1433
P1476
Chemotherapy-evoked neuropathi ...... ression by acetyl-L-carnitine.
@en
P2093
Gary J Bennett
Wen Hua Xiao
P2860
P304
P356
10.1016/J.PAIN.2007.06.001
P407
P577
2007-07-30T00:00:00Z